Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Mar Biotechnol (NY) ; 22(1): 19-30, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31728706

RESUMEN

The gold and cream colors of cultured Akoya pearls, as well as natural yellow nacre of pearl oyster shells, are thought to arise from intrinsic yellow pigments. While the isolation of the yellow pigments has been attempted using a large amount of gold pearls, the substance concerned is still unknown. We report here on the purification and characterization of yellow pigments from the nacre of Akoya pearl oyster shells. Two yellow components, YC1 and YC2, were isolated from the HCl-methanol (HCl-MeOH) extract from nacreous organic matrices obtained by decalcification of the shells with ethylenediaminetetraacetic acid (EDTA). Energy-dispersive X-ray and infrared spectroscopy analyses suggested that YC1 and YC2 precipitated under basic conditions are composed of Fe-containing inorganic and polyamide-containing organic compounds, respectively. YC1 solubilized under acidic conditions exhibited positive reactions to KSCN and K4[Fe(CN)6] reagents, showing the same ultraviolet-visible absorption spectrum as those of Fe(III)-containing compounds. In addition, X-ray absorption fine structure analysis supported the compound in the form of Fe(III). The total amount of Fe was approximately 2.6 times higher in the yellow than white nacre, and most Fe was fractionated into the EDTA-decalcifying and HCl-MeOH extracts. These results suggest that Fe(III) coordinated to EDTA-soluble and insoluble matrix compounds are mainly associated with yellow color development not only in the Akoya pearl oyster shells but also in the cultured Akoya pearls.


Asunto(s)
Compuestos de Hierro/química , Nácar/química , Pinctada/química , Exoesqueleto/química , Animales , Color , Pigmentación
2.
Cancer Sci ; 94(3): 302-7, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12824926

RESUMEN

Soluble Fas (sFas) has the ability to block Fas-mediated apoptosis, suggesting that sFas at tumor sites might inhibit tumor cell-killing by immune effector cells. We examined the sFas level in pleural effusion associated with lung cancer. The level of sFas in malignant pleural effusion was significantly higher than those in transudate and tuberculous pleural effusion. There was no significant difference in the sFas concentration among various histological types of lung cancer. The cytotoxicity mediated by anti-Fas agonistic antibody against Jurkat cells was inhibited by the addition of malignant pleural effusion, being inversely correlated with the sFas concentration. When Fas expression was examined using flow cytometry, eight of ten (80%) lung cancer cell lines expressed cell surface Fas. On the other hand, sFas protein and mRNA were detected in six of ten (60%) lung cancer cell lines, but there was no correlation between Fas and sFas expression. Furthermore, although the expressions of Fas and sFas were clearly detected in tumor cells derived from malignant effusion, the sFas expression was down-regulated in an in vitro culture. These results suggest that sFas in malignant pleural effusion is at least in part produced by lung cancer cells, and might play a role in local immunosuppression by tumor cells.


Asunto(s)
Neoplasias Pulmonares/genética , Derrame Pleural/patología , Receptor fas/análisis , Receptor fas/genética , Actinas/genética , Secuencia de Bases , Supervivencia Celular/inmunología , Cartilla de ADN , ADN Complementario/genética , Humanos , Células Jurkat , Neoplasias Pulmonares/inmunología , Neoplasias Pulmonares/patología , Derrame Pleural/genética , Derrame Pleural/inmunología , ARN Mensajero/genética , Tuberculosis/genética
3.
J Leukoc Biol ; 73(5): 621-9, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12714577

RESUMEN

We examined the mechanisms involved in interleukin (IL)-12-mediated suppression of cellular immunity in mice using allogeneic mixed leukocyte reaction (MLR) stimulated by dendritic cells (DCs) in vitro and compared the effect of IL-12 on MLR in mice and humans. Although IL-12 stimulated human MLR, the addition of IL-12 or interferon-gamma (IFN-gamma) resulted in a dose-dependent suppression of MLR in mice. The treatment with N(G)-monomethyl-L-arginine (L-NMMA) completely abrogated IL-12- and IFN-gamma-mediated suppression of MLR in mice. Furthermore, IL-12 enhanced the alloreactive cytolytic T lymphocyte (CTL) induction in human MLR, whereas the addition of L-NMMA was required to generate alloreactive CTLs in the presence of IL-12 in mice. Nitric oxide (NO) was detected only in mouse MLR. Murine DCs could produce NO, but neither human CD34(+) cell- nor monocyte-derived DCs produced a detectable amount of NO. These results suggest that NO produced by DCs might play an important role in IL-12-mediated immune suppression in mice but not in humans.


Asunto(s)
Células Dendríticas/inmunología , Interleucina-12/farmacología , Óxido Nítrico/fisiología , Linfocitos T Citotóxicos/efectos de los fármacos , Animales , Presentación de Antígeno , Células de la Médula Ósea/inmunología , Células de la Médula Ósea/metabolismo , Células Dendríticas/metabolismo , Femenino , Humanos , Tolerancia Inmunológica/fisiología , Inmunidad Celular/efectos de los fármacos , Interferón gamma/farmacología , Prueba de Cultivo Mixto de Linfocitos , Linfoma de Células T/patología , Mastocitoma/patología , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico/biosíntesis , Donantes de Óxido Nítrico/farmacología , S-Nitroso-N-Acetilpenicilamina/farmacología , Especificidad de la Especie , Linfocitos T Citotóxicos/inmunología , Células Tumorales Cultivadas , omega-N-Metilarginina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA